Fritz G. Buchanan

1.5k total citations
9 papers, 348 citations indexed

About

Fritz G. Buchanan is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Fritz G. Buchanan has authored 9 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Fritz G. Buchanan's work include Cell death mechanisms and regulation (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Fritz G. Buchanan is often cited by papers focused on Cell death mechanisms and regulation (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Fritz G. Buchanan collaborates with scholars based in United States, Netherlands and Spain. Fritz G. Buchanan's co-authors include Jonathan A. Meulbroek, Peter J. DeVries, Neal Goodwin, Hugh D. Falls, Andrew C. Phillips, Edward B. Reilly, Dong Cheng, Suzanne M. Norvell, Laura M. McKay and Kedar S. Vaidya and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Fritz G. Buchanan

9 papers receiving 340 citations

Peers

Countries citing papers authored by Fritz G. Buchanan

Since Specialization

Citations

This map shows the geographic impact of Fritz G. Buchanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fritz G. Buchanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fritz G. Buchanan more than expected).

Fields of papers citing papers by Fritz G. Buchanan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fritz G. Buchanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fritz G. Buchanan. The network helps show where Fritz G. Buchanan may publish in the future.

Co-authorship network of co-authors of Fritz G. Buchanan

This figure shows the co-authorship network connecting the top 25 collaborators of Fritz G. Buchanan. A scholar is included among the top collaborators of Fritz G. Buchanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fritz G. Buchanan. Fritz G. Buchanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia 2023 ·Blood ·Stephen K. Tahir, Emiliano Calvo, Benedito A. Carneiro, Junichiro Yuda, Aditya Shreenivas, Mojca Jongen‐Lavrencic, Eelke Gort, Kenichi Ishizawa, Daniel Morillo, (unknown), Morey L. Smith, Cheng Dong, Monica Motwani, David Sharon, Tamar Uziel, Dimple Modi, Fritz G. Buchanan, Susan E. Morgan-Lappe, Bruno C. Medeiros, Darren C. Phillips	9
2	Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors 2021 ·Cancer Research ·Darren C. Phillips, Fritz G. Buchanan, Dong Cheng, Larry R. Solomon, Xiao Yu, John Xue, Stephen K. Tahir, Morey L. Smith, Haichao Zhang, D. L. Widomski, Vivek C. Abraham, Nan Xu, Zhihong Liu, Li Zhou, Enrico L. DiGiammarino, Xin Lü, Nandini Rudra-Ganguly, Bruce A. Trela, Susan E. Morgan-Lappe	32
3	Utilization of 18F-Fluorodeoxyglucose–Positron Emission Tomography To Understand the Mechanism of Nicotinamide Phosphoribosyltransferase Inhibitors In Vivo 2019 ·Journal of Pharmacology and Experimental Therapeutics ·Sarah R. Mudd, Martin J. Voorbach, Dong Cheng, Min Cheng, Jun Guo, Wenqing Gao, Fritz G. Buchanan, Chris Tse, Julie L. Wilsbacher	3
4	Investigation of biaryl heterocycles as inhibitors of Wee1 kinase 2019 ·Bioorganic & Medicinal Chemistry Letters ·Anthony Mastracchio, Chunqiu Lai, Maricel Torrent, Kenneth D. Bromberg, Fritz G. Buchanan, Debra C. Ferguson, (unknown), Eric F. Johnson, Loren Lasko, David Maag, Alexander R. Shoemaker, Thomas D. Penning	5
5	ABT-414, an Antibody–Drug Conjugate Targeting a Tumor-Selective EGFR Epitope 2016 ·Molecular Cancer Therapeutics ·Andrew C. Phillips, Erwin R. Boghaert, Kedar S. Vaidya, Michael J. Mitten, Suzanne M. Norvell, Hugh D. Falls, Peter J. DeVries, Dong Cheng, Jonathan A. Meulbroek, Fritz G. Buchanan, Laura M. McKay, Neal Goodwin, Edward B. Reilly	136
6	The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia 2015 ·PLoS ONE ·William N. Pappano, Jun Guo, Yupeng He, Debra C. Ferguson, Sujatha Jagadeeswaran, Donald J. Osterling, Wenqing Gao, Julie K. Spence, Marina Pliushchev, Ramzi F. Sweis, Fritz G. Buchanan, Michael R. Michaelides, Alexander R. Shoemaker, Chris Tse, Gary G. Chiang	69
7	Characterization of ABT-806, a Humanized Tumor-Specific Anti-EGFR Monoclonal Antibody 2015 ·Molecular Cancer Therapeutics ·Edward B. Reilly, Andrew C. Phillips, Fritz G. Buchanan, Gillian A. Kingsbury, Yumin Zhang, Jonathan A. Meulbroek, Todd Cole, Peter J. DeVries, Hugh D. Falls, (unknown), Jinming Gu, Enrico L. DiGiammarino, Joann P. Palma, Cherrie K. Donawho, Neal Goodwin, Andrew M. Scott	62
8	Pyrimidine-Based Tricyclic Molecules as Potent and Orally Efficacious Inhibitors of Wee1 Kinase 2014 ·ACS Medicinal Chemistry Letters ·Yunsong Tong, Maricel Torrent, Alan S. Florjancic, Kenneth D. Bromberg, Fritz G. Buchanan, Debra C. Ferguson, Eric F. Johnson, Loren Lasko, David Maag, Philip J. Merta, Amanda M. Olson, Donald J. Osterling, Nirupama B. Soni, Alexander R. Shoemaker, T.M. Penning	18
9	Reversal of oncogene transformation and suppression of tumor growth by the novel IGF1R kinase inhibitor A-928605 2009 ·BMC Cancer ·William N. Pappano, Paul Jung, Jonathan A. Meulbroek, Yichun Wang, Robert D. Hubbard, Qian Zhang, (unknown), Niru B. Soni, Eric F. Johnson, George S. Sheppard, Cherrie K. Donawho, Fritz G. Buchanan, Steven K. Davidsen, Randy L. Bell, Jieyi Wang	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact